X0306 4 2020-05-19 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001257809 MCCORMICK FRANK C/O BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO CA 94301 0 1 0 0 Chairman of Oncology Common Stock 2020-05-19 4 A 0 39042 0.00 A 1300568 D Stock Option (Right to Buy) 1.05 2020-05-19 4 A 0 10549 0.00 A 2020-05-19 2029-09-17 Common Stock 10549 10549 D The shares were acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in privately-held subsidiaries of the Issuer (each, a "Subsidiary" and collectively, the "Subsidiaries"). The option was acquired in connection with an equity exchange program involving the issuance of equity awards under the Issuer's 2019 Stock Option and Incentive Plan in exchange for existing equity held by the Reporting Person in Subsidiaries of the Issuer. The number of option shares and per share exercise price of the new option was determined based on the number of shares and per share exercise price of the subsidiary option at a certain exchange ratio. /s/ Tara Condon, Attorney-in-Fact 2020-05-21